BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hoteit R, Taher A, Nassar R, Otrock Z, Halawi R, Mahfouz RA. Frequency of Triple Mutations Involving Factor V, Prothrombin, and Methylenetetrahydrofolate Reductase Genes Among Patients Referred for Molecular Thrombophilia Workup in a Tertiary Care Center in Lebanon. Genetic Testing and Molecular Biomarkers 2012;16:223-5. [DOI: 10.1089/gtmb.2011.0114] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Hoteit R, Hassanieh S, Mahfouz RA. Comparison of the performance of the Cepheid Xpert HemosIL Factor II and Factor V and the ViennaLab FV-PTH-MTHFR StripAssay kits for molecular thrombophilia profiling. Genet Test Mol Biomarkers 2014;18:183-6. [PMID: 24401045 DOI: 10.1089/gtmb.2013.0379] [Reference Citation Analysis]
2 Nassar H, Zaghal A, Taher A, Mafouz R, Safadi B, Kanso M, Khalife M, Faraj W. Triple thrombophilic simultaneous mutations in patients after bariatric surgery: is there a role for screening in the Eastern Mediterranean? J Surg Case Rep 2018;2018:rjy135. [PMID: 29942483 DOI: 10.1093/jscr/rjy135] [Reference Citation Analysis]
3 Abu-Heija A. Thrombophilia and Recurrent Pregnancy Loss: Is heparin still the drug of choice? Sultan Qaboos Univ Med J 2014;14:e26-36. [PMID: 24516750 DOI: 10.12816/0003333] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
4 El Hasbani G, Taher AT. Should we screen Eastern Mediterranean COVID-19 patients for inherited thrombophilia? Med Hypotheses 2021;152:110621. [PMID: 34116360 DOI: 10.1016/j.mehy.2021.110621] [Reference Citation Analysis]